Monday, March 1, 2021

Artiva Biotherapeutics Finds $120M In Series B

San Diego-based biopharmaceuticals company Artiva Biotherapeutics has raised a big, $120M funding round, in its Series B funding, according to the company. The funding was led by Venrock Healthcare Capital Partners, and also included Acuta Capital Partners, Cormorant Asset Management, EcoR1 Capital, Franklin Templeton, Janus Henderson Investors, Logos

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.